Nyrada
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
828 Pacific Hwy L 4 Ste 3, Gordon, New S...Phone Number
+61 290531990Website
www.nyrada.comRevenue
<$5 MillionStock Symbol
NYRIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nyrada
Nyrada is a pre-clinical stage biotechnology company focused on developing novel small molecule drugs to address cardiovascular, neurodegenerative, and chronic inflammatory diseases. The company aims to become a high-growth bio-pharmaceutical entity specializing in drug discovery and early-stage development, particularly targeting areas with significant unmet clinical needs. Nyrada's current drug development programs include a PCSK9 inhibitor for high LDL-cholesterol, a neuroprotectant for stroke and traumatic brain injury, a treatment for pain from peripheral nerve damage, and a drug for autoimmune diseases like psoriasis. Their innovative approach centers around the benzopyran molecular scaffold to create effective and well-tolerated therapies.Explore more
Nyrada Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nyrada your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Nyrada had a recent Job posting/layoffs
Check out if Nyrada is spiking on competitors!
Earning: See what the market has to say on Nyrada recently announced quarterly report
Website visits: Recent activity has been detected on your website
Nyrada, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Nyrada has new funding data
Congratulate Masked Content for being promoted to Masked Content at Nyrada
Product Launch: Get notified when Nyrada launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Nyrada has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Nyrada as Masked Content
Find 3 more new buyers
Compare Similar Companies to Nyrada
Compare insights from companies similar to Nyrada, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nyrada is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nyrada is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nyrada.
Nyrada financials insights
Gather financial insights about Nyrada, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Stock Offering
$11M
Nyrada Tech Stack
A closer look at the technologies used by Nyrada
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Person-Based
Person-Based
Person-Based
Nyrada News & Media
Nyrada Reaches AU$207m Market Cap Benefiting Insider Stock Buying
Insiders who bought Nyrada Inc. ( ASX:NYR ) stock in the last 12 months were richly rewarded last week. The company's...Nyrada Secures AU$3.5 Million R&D Tax Rebate for Fiscal Year 2023; Shares Surge 30%
-- Nyrada secured a rebate worth AU$3.54 million from the Australian government’s research and development tax incentive scheme for the fiscal year ended June 30, the drug development firm said on...Nyrada First Half 2023 Earnings: AU$0.017 loss per share (vs AU$0.018 loss in 1H 2022)
Nyrada ( ASX:NYR ) First Half 2023 Results Key Financial Results Revenue: AU$955.4k (up by AU$951.1k from 1H 2022). Net...Nyrada (ASX:NYR) Is In A Good Position To Deliver On Growth Plans
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Nyrada
Sign Up For FreeTo access detailed company insights
Nyrada is a pre-clinical stage biotechnology company focused on developing novel small molecule drugs to address cardiovascular, neurodegenerative, and chronic inflammatory diseases. The company aims to become a high-growth bio-pharmaceutical entity specializing in drug discovery and early-stage development, particularly targeting areas with signif... Read More
